Gemini Adds to Executive Leadership Team

Gemini named Donald O’Neil as chief commercial officer. Don has over 20 years of relevant life sciences experience. His previous roles include responsibilities for Invitrogen’s global reagents business, now owned by Thermo Fisher, and MilliporeSigma’s Cell Biology and Detection Solutions business segments. He was most recently senior vice president of sales and Strategic Partnerships at ORFLO Technologies, a life science instruments company. He will lead Gemini’s commercial efforts across a 14-person sales and marketing team. 

Brendan Lucey has been appointed vice president of Business Development. Brendan has over 17 years of industry experience, including roles as an executive at PE-backed ILC Dover, Sartorius Stedim, a leading biopharma tools company, and Lonza a leading contract development and manufacturing organization. Brendan’s background aligns him well with Gemini’s life science ecosystem. He will be a key driver of the Company’s deeper penetration into the biotech industry channel across sales, OEM and distribution partnerships. Brendan also serves on the board of Bioprocess Systems Alliance (BPSA), an industry group focused on single use biologics manufacturing. 

Dale Gordon, CEO of Gemini, stated, "I am thrilled to welcome Don and Brendan to the Gemini team. I have known Don for over 10 years, and strongly believe that his industry experience in the cell culture space will be instrumental in leading Gemini’s sales and marketing organization. Furthermore, Brendan’s scientific expertise and leadership in continuous manufacturing will bolster Gemini’s strategic partnerships. With our well-rounded management team, I look forward to continuing Gemini’s growth in providing high quality products and services to our customers across cell and gene therapy, biotechnology, and academic research." 

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com